Mutual Of America Capital Management LLC Mirati Therapeutics, Inc. Transaction History

Mutual Of America Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$132.13 - $177.45 $2.05 Million - $2.76 Million	-15,528 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$144.0 - $179.73 $2.02 Million - $2.52 Million	-14,019 Reduced 47.45%	15,528 $2.51 Million
Q1 2021 May 13, 2021	SELL	$158.92 - $221.61 $32,578 - $45,430	-205 Reduced 0.69%	29,547 $5.06 Million
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $1.52 Million - $2.25 Million	9,367 Added 45.95%	29,752 $6.54 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $300,139 - $443,265	-2,650 Reduced 11.5%	20,385 $3.39 Million
Q2 2020 Aug 06, 2020	BUY	$72.01 - $120.39 $1.66 Million - $2.77 Million	23,035 New	23,035 $2.63 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.